Global Avian Antisera 麻豆原创 Research Report 2025

Publication ID:

PB501258077

Publication Date:

January 14, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Avian Antisera was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Avian antisera refers to a type of antiserum produced in birds, typically in chickens or other avian species. Antiserum is a blood serum that contains antibodies against specific antigens. Antigens are foreign substances, such as bacteria, viruses, or toxins, that stimulate an immune response in an organism.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 587%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Avian Antisera, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avian Antisera.
The Avian Antisera market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Avian Antisera market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Avian Antisera manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Charles River
GD Animal Health
Jackson ImmunoResearch Inc
Abcam plc
Merck KGaA
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc
Segment by Type
Liquid State
Lyophilized State
Segment by Application
Pharmaceutical and Biological Companies
Animal Hospital
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Avian Antisera manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Avian Antisera in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Avian Antisera 麻豆原创 Overview
1.1 Product Definition
1.2 Avian Antisera by Type
1.2.1 Global Avian Antisera 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Liquid State
1.2.3 Lyophilized State
1.3 Avian Antisera by Application
1.3.1 Global Avian Antisera 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Pharmaceutical and Biological Companies
1.3.3 Animal Hospital
1.3.4 Others
1.4 Global Avian Antisera 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Avian Antisera Revenue 2020-2031
1.4.2 Global Avian Antisera Sales 2020-2031
1.4.3 Global Avian Antisera 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Avian Antisera 麻豆原创 Competition by Manufacturers
2.1 Global Avian Antisera Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Avian Antisera Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Avian Antisera Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Avian Antisera, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Avian Antisera, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Avian Antisera, Product Type & Application
2.7 Global Key Manufacturers of Avian Antisera, Date of Enter into This Industry
2.8 Global Avian Antisera 麻豆原创 Competitive Situation and Trends
2.8.1 Global Avian Antisera 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Avian Antisera Players 麻豆原创 Share by Revenue
2.8.3 Global Avian Antisera 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Avian Antisera 麻豆原创 Scenario by Region
3.1 Global Avian Antisera 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Avian Antisera Sales by Region: 2020-2031
3.2.1 Global Avian Antisera Sales by Region: 2020-2025
3.2.2 Global Avian Antisera Sales by Region: 2026-2031
3.3 Global Avian Antisera Revenue by Region: 2020-2031
3.3.1 Global Avian Antisera Revenue by Region: 2020-2025
3.3.2 Global Avian Antisera Revenue by Region: 2026-2031
3.4 North America Avian Antisera 麻豆原创 Facts & Figures by Country
3.4.1 North America Avian Antisera 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Avian Antisera Sales by Country (2020-2031)
3.4.3 North America Avian Antisera Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Avian Antisera 麻豆原创 Facts & Figures by Country
3.5.1 Europe Avian Antisera 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Avian Antisera Sales by Country (2020-2031)
3.5.3 Europe Avian Antisera Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Avian Antisera 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Avian Antisera 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Avian Antisera Sales by Region (2020-2031)
3.6.3 Asia Pacific Avian Antisera Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Avian Antisera 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Avian Antisera 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Avian Antisera Sales by Country (2020-2031)
3.7.3 Latin America Avian Antisera Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Avian Antisera 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Avian Antisera 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Avian Antisera Sales by Country (2020-2031)
3.8.3 Middle East and Africa Avian Antisera Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Avian Antisera Sales by Type (2020-2031)
4.1.1 Global Avian Antisera Sales by Type (2020-2025)
4.1.2 Global Avian Antisera Sales by Type (2026-2031)
4.1.3 Global Avian Antisera Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Avian Antisera Revenue by Type (2020-2031)
4.2.1 Global Avian Antisera Revenue by Type (2020-2025)
4.2.2 Global Avian Antisera Revenue by Type (2026-2031)
4.2.3 Global Avian Antisera Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Avian Antisera Price by Type (2020-2031)
5 Segment by Application
5.1 Global Avian Antisera Sales by Application (2020-2031)
5.1.1 Global Avian Antisera Sales by Application (2020-2025)
5.1.2 Global Avian Antisera Sales by Application (2026-2031)
5.1.3 Global Avian Antisera Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Avian Antisera Revenue by Application (2020-2031)
5.2.1 Global Avian Antisera Revenue by Application (2020-2025)
5.2.2 Global Avian Antisera Revenue by Application (2026-2031)
5.2.3 Global Avian Antisera Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Avian Antisera Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Charles River
6.1.1 Charles River Company Information
6.1.2 Charles River Description and Business Overview
6.1.3 Charles River Avian Antisera Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Charles River Avian Antisera Product Portfolio
6.1.5 Charles River Recent Developments/Updates
6.2 GD Animal Health
6.2.1 GD Animal Health Company Information
6.2.2 GD Animal Health Description and Business Overview
6.2.3 GD Animal Health Avian Antisera Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GD Animal Health Avian Antisera Product Portfolio
6.2.5 GD Animal Health Recent Developments/Updates
6.3 Jackson ImmunoResearch Inc
6.3.1 Jackson ImmunoResearch Inc Company Information
6.3.2 Jackson ImmunoResearch Inc Description and Business Overview
6.3.3 Jackson ImmunoResearch Inc Avian Antisera Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jackson ImmunoResearch Inc Avian Antisera Product Portfolio
6.3.5 Jackson ImmunoResearch Inc Recent Developments/Updates
6.4 Abcam plc
6.4.1 Abcam plc Company Information
6.4.2 Abcam plc Description and Business Overview
6.4.3 Abcam plc Avian Antisera Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abcam plc Avian Antisera Product Portfolio
6.4.5 Abcam plc Recent Developments/Updates
6.5 Merck KGaA
6.5.1 Merck KGaA Company Information
6.5.2 Merck KGaA Description and Business Overview
6.5.3 Merck KGaA Avian Antisera Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck KGaA Avian Antisera Product Portfolio
6.5.5 Merck KGaA Recent Developments/Updates
6.6 Thermo Fisher Scientific
6.6.1 Thermo Fisher Scientific Company Information
6.6.2 Thermo Fisher Scientific Description and Business Overview
6.6.3 Thermo Fisher Scientific Avian Antisera Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Thermo Fisher Scientific Avian Antisera Product Portfolio
6.6.5 Thermo Fisher Scientific Recent Developments/Updates
6.7 Bio-Rad Laboratories, Inc
6.7.1 Bio-Rad Laboratories, Inc Company Information
6.7.2 Bio-Rad Laboratories, Inc Description and Business Overview
6.7.3 Bio-Rad Laboratories, Inc Avian Antisera Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Rad Laboratories, Inc Avian Antisera Product Portfolio
6.7.5 Bio-Rad Laboratories, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Avian Antisera Industry Chain Analysis
7.2 Avian Antisera Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Avian Antisera Production Mode & Process Analysis
7.4 Avian Antisera Sales and 麻豆原创ing
7.4.1 Avian Antisera Sales Channels
7.4.2 Avian Antisera Distributors
7.5 Avian Antisera Customer Analysis
8 Avian Antisera 麻豆原创 Dynamics
8.1 Avian Antisera Industry Trends
8.2 Avian Antisera 麻豆原创 Drivers
8.3 Avian Antisera 麻豆原创 Challenges
8.4 Avian Antisera 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Charles River
GD Animal Health
Jackson ImmunoResearch Inc
Abcam plc
Merck KGaA
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.